We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
133 hedge funds and large institutions have $2.52B invested in Puma Biotechnology in 2015 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 41 increasing their positions, 59 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
104% more call options, than puts
Call options by funds: $67.1M | Put options by funds: $32.8M
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
11% more capital invested
Capital invested by funds: $2.27B → $2.52B (+$252M)
5.94% more ownership
Funds ownership: 93.32% → 99.26% (+5.9%)
18% less funds holding
Funds holding: 163 → 133 (-30)
31% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 59
62% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 47
Holders
133
Holders Change
-30
Holders Change %
-18.4%
% of All Funds
3.49%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
18
Increased
41
Reduced
59
Closed
47
Calls
$67.1M
Puts
$32.8M
Net Calls
+$34.2M
Net Calls Change
-$86.7M
Top Buyers
| 1 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$96M |
| 2 |
O
OrbiMed
New York
|
+$81.9M |
| 3 |
Millennium Management
New York
|
+$79.7M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$30.7M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$20.7M |
Top Sellers
| 1 |
Franklin Resources
San Mateo,
California
|
-$52.3M |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$49M |
| 3 |
T
TOBAM
Paris,
France
|
-$24M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$16.7M |
| 5 |
JP Morgan Chase
New York
|
-$14.9M |